ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intran...
Q1 2026
May 15, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 13, 2025